Vara has secured the world's first regulatory approval for an AI tool that autonomously classifies certain mammograms as normal, bypassing radiologist review.
Key Details
- 1Vara's breast triage tool received CE Certification under EU Medical Device Regulation.
- 2The AI autonomously flags normal screening mammograms; others are read by at least one radiologist.
- 3Designed to support organized population screening, especially in areas facing radiologist shortages.
- 4Atmon system continually monitors performance and can revert to full radiologist review if quality signals deteriorate.
- 5The approval aligns with new EU AI Act requirements for high-risk systems to have human oversight.
Why It Matters
This marks a breakthrough in AI autonomy for radiology, potentially alleviating radiologist workload and addressing workforce shortages in breast screening. The built-in safety mechanisms and regulatory oversight set a precedent for broader AI adoption and governance in imaging.
Source
Radiology Business
Related News
•Radiology Business
Webinar to Showcase Successful AI Automation in Radiology Workflows
A webinar will provide insights from imaging leaders on expanding and optimizing AI-driven automation in radiology clinical workflows.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.